SecureKloud Technologies Ltd
Incorporated in 1985, Securekloud Technologies Ltd deals in Enterprise Cloud Transformation services[1]
- Market Cap ₹ 66.8 Cr.
- Current Price ₹ 20.0
- High / Low ₹ 34.2 / 16.0
- Stock P/E
- Book Value ₹ -15.4
- Dividend Yield 0.00 %
- ROCE -5.97 %
- ROE %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -36.0% over past five years.
- Debtor days have increased from 57.2 to 93.7 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Services IT Enabled Services
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125 | 272 | 528 | 849 | 842 | 382 | 351 | 379 | 458 | 340 | 168 | 37 | |
| 87 | 183 | 344 | 556 | 671 | 409 | 313 | 462 | 530 | 400 | 188 | 42 | |
| Operating Profit | 38 | 89 | 185 | 293 | 171 | -27 | 37 | -82 | -71 | -60 | -20 | -5 |
| OPM % | 31% | 33% | 35% | 35% | 20% | -7% | 11% | -22% | -16% | -17% | -12% | -13% |
| 0 | 0 | 1 | 8 | 8 | -621 | -1 | 1 | 2 | 2 | 3 | -127 | |
| Interest | 0 | 0 | 2 | 11 | 13 | 15 | 16 | 12 | 12 | 20 | 20 | 7 |
| Depreciation | 9 | 20 | 14 | 25 | 70 | 10 | 18 | 11 | 18 | 17 | 8 | 1 |
| Profit before tax | 29 | 68 | 171 | 266 | 96 | -672 | 2 | -105 | -99 | -95 | -45 | -140 |
| Tax % | 20% | 22% | 24% | 23% | 17% | 0% | 23% | -7% | -1% | 1% | 1% | 0% |
| 23 | 53 | 129 | 205 | 80 | -675 | 1 | -98 | -99 | -96 | -46 | -141 | |
| EPS in Rs | 6.88 | 13.65 | 34.23 | 56.24 | 22.52 | -164.42 | 0.52 | -20.59 | -14.54 | -10.90 | -13.72 | -42.07 |
| Dividend Payout % | 0% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -36% |
| 3 Years: | -57% |
| TTM: | -78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | 72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -25% |
| 3 Years: | -18% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 15 | 15 | 15 | 15 | 15 | 16 | 17 | 17 | 17 | 17 |
| Reserves | 101 | 199 | 305 | 476 | 577 | 12 | 22 | 35 | 5 | -23 | 8 | -68 |
| 0 | 3 | 41 | 86 | 118 | 118 | 140 | 113 | 126 | 121 | 106 | 57 | |
| 40 | 101 | 148 | 241 | 287 | 98 | 90 | 148 | 140 | 81 | 105 | 13 | |
| Total Liabilities | 152 | 314 | 509 | 819 | 998 | 243 | 268 | 312 | 288 | 196 | 236 | 18 |
| 79 | 146 | 187 | 358 | 637 | 178 | 159 | 213 | 202 | 149 | 142 | 2 | |
| CWIP | 20 | 18 | 21 | 28 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 53 | 150 | 301 | 432 | 361 | 61 | 108 | 100 | 86 | 47 | 94 | 17 | |
| Total Assets | 152 | 314 | 509 | 819 | 998 | 243 | 268 | 312 | 288 | 196 | 236 | 18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 19 | 72 | 125 | 184 | 86 | 5 | -68 | -64 | 5 | -49 | ||
| -37 | -86 | -57 | -238 | -209 | -66 | 1 | -23 | -0 | 3 | 5 | ||
| 21 | 81 | 45 | 34 | 23 | -21 | 20 | 73 | 53 | -9 | 100 | ||
| Net Cash Flow | 10 | 14 | 61 | -79 | -2 | -0 | 27 | -19 | -11 | -1 | 56 | |
| Free Cash Flow | -10 | -67 | 34 | -64 | -113 | 86 | 5 | -71 | -65 | 4 | -49 | |
| CFO/OP | 68% | 21% | 57% | 64% | 143% | -320% | 23% | 81% | 90% | -4% | 235% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 108 | 89 | 109 | 103 | 48 | 57 | 64 | 53 | 35 | 43 | 94 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 82 | 108 | 89 | 109 | 103 | 48 | 57 | 64 | 53 | 35 | 43 | 94 |
| Working Capital Days | 48 | 95 | 88 | 107 | 59 | -98 | -93 | -67 | -79 | -141 | -188 | -493 |
| ROCE % | 26% | 33% | 46% | 46% | 14% | -6% | 11% | -46% | -42% | -51% | -18% | -6% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Days Sales Outstanding (DSO) Days |
|
||||||||||
| Geographic Revenue Share - USA % |
|||||||||||
| Revenue Vertical Share - Healthcare & Life Sciences % |
|||||||||||
| Employee Headcount Number |
|||||||||||
| Recurring Revenue Share % |
|||||||||||
| Top 5 Client Concentration % |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
2d - Board approved amended insider trading and fair disclosure code on May 30, 2026.
- Results- Financial Results For The Qtr/Yr Ended March 31, 2026 2d
-
Board Meeting Outcome for For Consideration & Approval Of Financial Results (Standalone & Consolidated) For The Qtr/Yr Ended March 31, 2026, Among Other Matters
2d - Board approved FY26 audited results, wrote off Rs10,112.19 lakh subsidiary investment, and appointed internal auditor.
-
Board Meeting Intimation for Considering And Approving The Audited Financial Results (Standalone & Consolidated) For The Qtr/Yr Ended March 31, 2026, Among Other Matters
29 May - Audit Committee and Board meetings rescheduled to May 30, 2026 for FY26 results approval.
-
Announcement Under Reg 30 (LODR) - Attachment Proceeding
22 May - SEBI issued attachment proceedings on May 20, 2026 for promoter securities sale after SAT order dated March 6, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Jan 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023TranscriptAI SummaryPPT
-
Aug 2022TranscriptPPT
-
Apr 2022TranscriptAI SummaryPPT
-
Jan 2022TranscriptPPT
-
Nov 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Jun 2021TranscriptPPT
-
Jan 2021TranscriptPPT
-
Nov 2020Transcript PPT
Business Overview:[1][2]
Company (formerly known as 8K Miles Ltd) provides digital transformation solutions including managed services, cloud enablement, cyber security, and AI powered data analytics. It deals in Blockchain, Cloud, Big Data, DevOps, Enterprise Security, Decision Engineering, and Managed Services. Company provides advanced security services like IDAM, MFA, and Governance Risk & Statutory Compliance for Enterprises which have adopted Cloud operations